Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-06

Clinical Trial Update: Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating cytokine-guided risk stratification and treatment for pediatric hemophagocytic lymphohistiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Hemophagocytic Lymphohistiocytoses, Cytokine Storm | Phase 4 | Status: UNKNOWN